OBN's Annual Awards celebrating outstanding achievements in the UK life sciences sector

OBN Annual Awards Categories

OBN Annual Awards 2015 – The Judges, Categories & Winners

This year’s 12 OBN Awards recognised and celebrated achievements in biotech, medtech and investment. Find out the winners of each award.

Judges

The judging panel featured an impressive line-up of international leaders and opinion formers from the life sciences sector, including:

David Evans, Chairman, Cytox Group

Graziano Seghezzi, Partner, Sofinnova Partners

Margarita Chavez, Director, Ventures & Early Stage Collaboration, Abbvie

Graeme Martin, President & CEO, Takeda Ventures

Deborah Harland, Partner, SR One

David Phillips, Partner, SR One

Andy Smith, CIO, Mann BioInvest

Melanie Goward, Deputy Fund Manager, Finance Wales

Maina Bhaman, Director, Healthcare Ventures, Imperial Innovations

Raman Minhas, Country Manager – UK, Hygieia

Goncalo de Vasconcelos, Co-Founder & CEO, SyndicateRoom

Best New UK Biotech Development Programme - Sponsored by PCI

PCI Supporter Logo 220x115

This category awards a company for products in development or recently at market for which clinical results have been announced and there has been news flow.

The Winner 2015:

Summit Therapeutics

Nominees included:

GW Pharmaceuticals

MGB Biopharma

Previous years winners:

Adaptimmune in 2014

 Circassia in 2013

Vertex in 2012

Best Emerging UK Biotech Company - Sponsored by J A Kemp

sponsor_jakemp

This award, kindly sponsored by J A Kemp, recognises which emerging biotech company in the UK has the most promise.  Companies will be less than five years old: includes diagnostics, development and platform technologies.

The Winner 2015:

Touchlight Genetics

Nominees included:

Inflection Biosciences

Ex Scientia

Previous years winners:

NightstaRx in 2014

Autifony Therapeutics in 2013

London Pharma in 2012

Best Emerging UK Biotech Fundraiser - Sponsored by Silicon Valley Bank

Silicon Valley Bank logo 155x70

This award considers the amount raised vs where company is on the development spectrum.  It is therefore partly based on quantum raised as well as the quality of the development programme.  Limited to companies with an estimated value of £500m.

The Winner 2015:

Adaptimmune

Nominees included:

Immunocore

Circassia Pharmaceuticals

Previous years winners:

Circassia in 2014

Karus Therapeutics in 2013

PsiOxus in 2012

Best UK Biotech Dealmaker - Sponsored by World Courier

World_Courier logo 220x115 23 10 2014

This award, kindly sponsored by World Courier,  celebrates who did the best deal in the last 15 months prior to the Award.  Limited to companies with an estimated valuation of less than £1bn.

The Winner 2015:

Hepatares Therapeutics

Nominees included:

Immunocore

Circassia Pharmaceuticals

Previous years winners:

Astex in 2014

Immunocore in 2013

EUSA Pharma in 2012

Best New UK Medtech Development Programme - Sponsored by Arthur J Gallagher

Arthur J Galagher logo 259x170

This award, kindly sponsored by Arthur J Gallagher, celebrates the best new medtech development programme in development or recently at market with new results or news flow.

The Winner 2015:

Accentus Medical

Nominees included:

Oxford Cancer Biomarkers

Brainomix

Previous years winners:

Isansys in 2014

OrganOx in 2013

Oxtex in 2012 for Medtech Product Award

Best Emerging UK Medtech Company - Sponsored by James Cowper Kreston

Jamescowperkreston New 259x170

This award, kindly sponsored by James Cowper Kreston, celebrates which emerging medtech company has the most promise.  Companies must be less than five years old, category includes medical technologies and diagnostics.

The Winner 2015:

OxSonics

Nominees included:

Oxford Cancer Biomarkers

Brainomix

Previous years winners:

Intelligent Ultrasound in 2014

Angle plc in 2013

FoetoH in 2012

Best Emerging UK Medtech Fundraiser - Sponsored by EY

sponsor_ey

This award, kindly sponsored by EY, considers the amount raised vs where company is on the development spectrum.  It is therefore partly based on quantum raised as well as the quality of the development programme.  Limited to companies with an estimated valuation of less than £500m.

The Winner 2015:

Oxford Nanopore Technologies

Nominees included:

Enigma Diagnostics

Quanta Fluid Solutions

Previous years winners:

Oxford Immunotec in 2014

Glide Pharma in 2013

Oxford Nanopore in 2012

Best UK Medtech Dealmaker - Sponsored by The BioHub Birmingham

BioHub Birmingham Logo JPEG

This award, kindly sponsored by the BioHub Birmingham, recognises who did the best deal in the last 15 months prior to the Award.  Limited to companies with an estimated valuation of less than £500m.

The Winner 2015:

Abingdon Health

Nominees included:

Oxford Cancer Biomarkers

DNA Electronics

Previous years winners:

Oxford Gene Technology in 2014

Oxford Gene Technology in 2013

SmartSensor Telemed in 2012

Best Emerging UK SynBio Company - Sponsored by SynbiCITE

SynbiCITE 220x115 supporter logo

Which emerging industrial or synthetic biotech company has the most promise. The company must be less than five years old.

The Winner 2015:

Oxitec

Nominees included:

Touchlight Genetics

Synpromics

 This was a new award category for 2015.

Highest Impact Investor

This award recognises which investment firm has had the highest impact upon the UK’s life sciences companies than any other, in the last 15 months prior to the Award.

The Winner 2015:

Woodford Patient Capital Trust

Nominees included:

Oxford Science Innovation

Imperial Innovations

Previous years winners:

Imperial Innovations in 2014

Technology Strategy Board in 2013

Imperial Innovations in 2012

Best Pharma BD&L Team - Sponsored by Premier Research

Print

This award, kindly sponsored by Premier Research, celebrates which company’s BD&L Team has had the highest impact in the 15 months prior to the Award.

Joint Winners 2015:

Astra Zeneca & Shire

Nominees included:

BTG

 Previous years winners:

Shire in 2014

Shire in 2013

AstraZeneca in 2012

Best Public-Private Collaboration – Sponsored by Oxford AHSN

Oxford AHSN logo 220x115

This award celebrates a public-private collaboration that has delivered most value in the 15 months prior to the Award.

The Winner 2015:

Isansys/Birmingham Children’s Hospital

Nominees included:

The DIABLO Consortium

Department of Psychiatry at the University of Oxford/National Institute for Health Research/P1vital

Previous years winners:

Cranfield University & Bedford Hospital NHS Trust in 2014